Risperidone tablets

DRUG2 trials

Sponsors

Janssen Korea, Ltd., Korea, Sumitomo Pharma (Suzhou) Co., Ltd.

Conditions

Schizophrenia

Phase 3

A Clinical Trial of Lurasidone in Treatment of Schizophrenia

CompletedNCT02002832

Sumitomo Pharma (Suzhou) Co., Ltd.Schizophrenia

Start: 2013-12-31End: 2015-11-30Updated: 2019-11-15

Phase 4

An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder

CompletedNCT00992407

Janssen Korea, Ltd., KoreaSchizophrenia

Start: 2007-12-31End: 2010-12-31Updated: 2014-03-11

Related Papers

TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia.

2024-10-093 citations

Assessment of Negative Symptoms in Clinical Trials of Acute Schizophrenia: Test of a Novel Enrichment Strategy

Schizophrenia Bulletin Open2022-01-018 citations